The global sacroiliac joint fusion market size is expected to be worth around US$ 761.45 million by 2030, according to a new report by Vision Research Reports.
The global sacroiliac joint fusion market size is expected to be worth around US$ 761.45 million by 2030, according to a new report by Vision Research Reports.
The global sacroiliac joint fusion market size was valued at US$ 190.5 million in 2020 and is anticipated to grow at a CAGR of 18.5% during forecast period 2021 to 2030.
Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39013
Growth Factors
Growing technological developments, the number of minimally invasive surgical procedures, reimbursement coverage, and initiatives by key companies are some of the key drivers of this market. As per AmeriHealth Caritas, by 2020, minimally invasive sacroiliac joint fusion was covered by Medicaid programs in 44 states in the U.S. while 32 Blue Cross Blue Shield plans covered minimally invasive joint fusion by 2019. This is anticipated to increase the number of MIS sacroiliac joint fusion procedures.
The COVID-19 pandemic resulted in logistical bottlenecks, decreased sales and marketing activities, low demand, and other challenges for market participants. The major impact during the pandemic, however, was canceled or postponed elective surgeries. As many countries went under lockdown and implemented movement restrictions, the number of elective surgeries plummeted. In addition, several healthcare institutions and regulatory bodies recommended the postponement of elective surgical procedures.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 761.45 million by 2030 |
| Growth Rate | CAGR of 18.5% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Indication, Surgery Type, Product, End-user |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | SI-BONE, Inc.; SIGNUS Medizintechnik GmbH; Globus Medical; Orthofix Medical Inc.; Life Spine, Inc.; Camber Spine Technologies, LLC; CoreLink Surgical; Xtant Medical; Surgalign Spine Technologies, Inc.; Medtronic |
COVID-19 Impact
The delayed elective surgeries hampered the market growth
The outbreak of COVID-19 resulted in reduced sales and low demand for the surgeries, thereby, hampering the market. The lockdown led to the postponement of elective surgeries and delayed clinical trials, taking the market graph down. The situation increased the need for innovation in healthcare facilities.
There was a tremendous rise in virtual medical services, however, various players faced losses. For instance, SI-BONE disclosed that its operations ran at low resources owing to the reduced demand for its iFuse product. The loss incurred by the company was due to the restrictions imposed on elective procedures owing to the pandemic.
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39013
By Indication Analysis
The degenerative sacroilitis segment held the largest revenue share of over 35.0% in 2020. The key factors contributing to this segment growth include a high prevalence of degenerative sacroilitis, growing awareness regarding the condition, and improving diagnostic capabilities for sacroiliac joint disorders.
The trauma segment is expected to expand at the highest CAGR of 18.7% from 2021 to 2030. Trauma indication is one of the most recently approved indications by the FDA, thus contributing to the segment growth.
By Surgery Type Analysis
The minimally invasive surgeries (MIS) segment held the largest revenue share of over 91.0% in 2020 and is estimated to expand at the fastest growth rate over the forecast period. The increasing preference for minimally invasive surgeries due to associated benefits such as smaller incisions.
According to the Washington State Health Care Authority’s 2021 report, minimally invasive SI joint fusion surgery was found to be more effective than open fusion for reducing pain. It is also associated with a shorter length of stay at the hospital.
By Product Analysis
The implants segment accounted for the largest revenue share of over 70.0% in 2020 and is projected to expand at the highest CAGR over the forecast period. The key factors contributing to the segment growth include the rising demand for safe and effective sacroiliac joint fusion systems and advancements in technology and materials used in these systems.
3D printing technology is gaining popularity in various applications of MIS such as bio modeling to optimize preoperative planning, manufacturing of implants, and hardware templates and guides.
By End-user Analysis
The hospitals segment dominated the market with a revenue share of over 45.0% in 2020. The key factors contributing to the segment growth include a higher volume of surgeries performed in hospitals and a growing preference for minimally invasive surgeries.
According to the Centers for Medicare & Medicaid Services (CMS), in March 2021, there were around 187 Medicare-certified ASCs in Washington state, 442 in Texas, 457 in Florida, 817 in California, and 368 in Georgia. In fact, as per Definitive Healthcare, LLC, there were about 9,280 active ASCs in 2019 in the U.S. These numbers are anticipated to increase over the forecast period.
By Regional Analysis
North America held the largest revenue share of over 40.0% in 2020. The growth of the regional market can be attributed to the presence of key players, advanced healthcare infrastructure, and growing reimbursement coverage. Asia Pacific is projected to expand at the fastest CAGRof 19.1% over the forecast period.
SI-BONE, Inc. reported the first iFuse procedures beyond its key markets of Europe and the U.S., in countries such as Canada, Israel, Japan, Australia, Hong Kong, New Zealand, Saudi Arabia, South Africa, and Turkey, thus expanding its regional presence.
Related Reports
- Bone And Joint Health Supplements Market Report 2022-2030 - https://www.visionresearchreports.com/bone-and-joint-health-supplements-market/39748
- Bone Grafts and Substitutes Market Report 2022-2030 - https://www.visionresearchreports.com/bone-grafts-and-substitutes-market/39128
- Joint Pain Injections Market Report 2022-2030 - https://www.visionresearchreports.com/joint-pain-injections-market/38754
Key Players
- SI-BONE, Inc.
- SIGNUS Medizintechnik GmbH
- Globus Medical
- Orthofix Medical Inc.
- Life Spine, Inc.
- Camber Spine Technologies, LLC
- CoreLink Surgical
- Xtant Medical
- Surgalign Spine Technologies, Inc.
- Medtronic
Market Segmentation
- By Indication
- Degenerative Sacroilitis
- Sacral Disruption
- Trauma
- By Surgery Type
- MIS
- Open
- By Product
- Implants
- Accessories
- By End-user
- Hospitals
- Ambulatory Surgical Centers
- Others (Specialty Centers, Research & Academic Institutes)
- Regional
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Click Here to View Full Report Table of Contents
Immediate Delivery Available | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39013
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://qyresearchmedical.com/